OraSure Technologies to Present at the Cowen & Co. Health Care Conference

  
    
  
  
    
      OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Ronald H. 
      Spair, Chief Operating Officer and Chief Financial Officer, will speak 
      to the investment community at the Cowen & Co. Health Care Conference in 
      Boston, Massachusetts. The conference will be simultaneously webcast 
      over the Internet.
    
    
      Mr. Spair is scheduled to speak on March 20, 2008, at approximately 
      10:15 am Eastern Time (7:15 am Pacific Time). Interested investors can 
      access the live webcast of the presentation by going to OraSure 
      Technologies’ web site, www.orasure.com, 
      and clicking on the Investor Info link. A replay of the webcast will be 
      available on OraSure Technologies’ web site 
      for seven days. Alternatively, you can access the live webcast of the 
      presentation via the following link http://www.cowen.com.
    
    
      About OraSure Technologies
    
    
      OraSure Technologies develops, manufactures and markets oral fluid 
      specimen collection devices using proprietary oral fluid technologies, 
      diagnostic products including immunoassays and other in vitro 
      diagnostic tests, and other medical devices. These products are sold in 
      the United States as well as internationally to various clinical 
      laboratories, hospitals, clinics, community-based organizations and 
      other public health organizations, distributors, government agencies, 
      physicians’ offices, and commercial and 
      industrial entities.
    
    
      OraSure Technologies is the leading supplier of oral-fluid collection 
      devices and in vitro diagnostic assays to the employment, 
      criminal justice, drug treatment, life insurance and public health 
      markets for the detection of abused drugs and the antibodies to HIV. 
      Based in Bethlehem, Pa., the company develops, manufactures and markets 
      oral specimen collection devices, in vitro diagnostic tests, and 
      other medical devices. For more information on the Company, please go to www.orasure.com.